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ABSTRACT 
An extract from Eisenia bicyclis containing -principally 
a polyphenolic polymer was examined for pharmacological ac-
tivity. The investi gat ion centered around the established 
activity of a model polyphenolic compound, phloroglucinol. 
Studies on inflammation and alteration of hepatic microsomal 
enzyme activity were also performed. 
Heat denat uration of a 0.15 % bovine serum albumin solu-
tion was inhibited 96% by the addition of the material at a 
final concentration of 0.32 mg/ml. Since stabilization of 
such solutions is often indicative 9f anti-inflammatory ac-
tivity, direct me asurements of this. activity were made . The 
inhibition of formation of carageenin-induced rat paw edema 
was utilized as a test system. As determined by paw volume 
changes, administration of a dose of 75 mg/kg (ip) one hour 
prior to carrageenin injection inhibited edema production by 
88%. The potent anti-inflammatory agent phenylbutazone, at 
a dose of 90 mg/kg (ip), provided 100% protection. The pro-
tection given by the Eisenian extract apparently was not due 
to pituitary-adrenal stimulation, since the protection is 4- · 
fold better than that given by a dose of 50 mg/kg ( ip ) of 
cortisone. The effect cannot be attributed to changes in 
body temperature, which r emains unchanged . The effect can 
be partially but not completely attributed to the irr·itant 
i 
properties of the material since buffering a dose of 100 
mg/kg (ip) provided 42% protection. The effect is partially 
due to stabilization of the lysosomal membrane since in 
vitro 309 ug of the extract per milliliter of incubation 
media inhibited by 64 % the release of the marker enzyme 
8-glucuronidase from lysosomes. The compound administered 
at a dose of 75 mg/kg (ip) daily for 17 days offered no 
protection against rat paw edema induced by Freund's com-
plete adjuvant. 
Capillary fragility was determined by mouse lung hemo-
globin content following sudden decompression. No decrease 
in fra gility was observed 1.5 hours after pretreatment with 
the extract at a dose o f 300 mg/kg (ip). 
The material administered to mice (300 mg/kg , ip) 30 
minutes prior to administration of lethal doses of curare 
exhibited p1"otection when the curare was also given by the 
intraperitoneal route . No protection was exhibited when the 
curare was administered subcutaneously, This s uggested a 
chemical rather than a pharmacological antagonism. Th:l.s 
hypothesis was supported when no hlltagon1sm was found to the 
action of curare on the cat gastrocnemius muscle in vivo by 
jugular infusion of 180 mg of the extract, and when a dose 
of 300 mg/kg (ip) one hour pr~or to sacrifice was found to 
have no effect on the activity of rat brain cholinesterase. 
The extract offered no antagonism to the action of either 
strychnine or tetrodotoxin. 
No chan ge in rat liver mi crosomal enzyme activity, as 
ii 
determined by the extent of metabolism of 0-ethyl 
0-(4-nitrophenyl) phenylphosphonothioate (EPN1 was found 
after the administration of 300 mg/kg (ip) of the material 
daily for 3 days. Also, a single injection of 300 mg/kg (ip) 
1 hour prior to sacrifice for measurement of activity was 
without effect. 
Estrogenic activity was assayed by changes in uterine 
weight in the immature female rat. The administration of 
300 mg/kg of the extract intraperitoneally daily for 3 days 
did not alter uterine weight . 
Rat liver homogenates were assayed for tryptophan 
pyrrolase activity by measuring the formation of the end-
product kynurenine. The administration of 300 mg/kg (ip) of 
the extract 1.5 hours prior to sacrifice caused 33% inhibi-
tion of the enzyme activity . The presence of the extract at 
a concentration of 486 µg/ml resulted in an in vitro inhi-
bition of 82%. 
iii 
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I INTRODUCTION 
Many naturally derived compounds are used extensively 
in medicine . Some outstanding examples are digitalis, re-
serpine, atropine, and colchicine. Despite the awareness of 
the origins of such drugs from terrestrial plants, until 
recently there has been relatively little effort made to 
examine marine species for pharmacolo gical agents. Exten-
sive research is needed in this are a , considering that of 
the 500,000 species which inhabit the water, less than one 
percent have been examined for biological activity. 
The drugs whi ch have been isolated from marine plants 
exhibit a wide variety of pharmacological activity. The 
following are some representative examples (Der Marderosian, 
1969). The fungus Ce phalosporium acremonium is the source 
of cephalothin , an antibiotic which is active against various 
penicill in-resistant microbes. The algae Lyngbya majuscula 
has been implicated in outbreaks of dermatitis among swimmers, 
and toxicity in fi sh and mice. However, extracts of this 
algae have also shown antimicrobial, antiviral , fungicidal, 
and other types of growth-inhibitory properties in prelim-
inary pharmacological studies. The algae Digenea simplex 
has yielded the anthelmintic kainic acid. Chondrus crispus 
is the source of the linear polysaccharide carrageenin, 
which exhibits antipeptic, anticoagulant, and antithrombic 
properties. More thorough screening programs would un-
doubtedly uncover more agents from just these four species. 
In this study, an extract from the algae Eisenia 
bicyclis (Kjel lman ) Setchell, native to the shores of Korea, 
containing principally a polyphenolic polymer, has been 
examined for pharmacological activity. The investigation 
centered· around the established activity of a model poly-
phenolic compound, phloroglucinol, or 1,3,5-trihydroxybenzene. 
Studies on inflammation and alteration of hepatic microsomal 
enzyme activity were also performed. 
II REVIEW OF THE LITERATURE 
The pharmacological activity of phloroglucinol (1,3,5-
trihydroxybenzene) has been investigated by several groups. 
Okanishi and Shimaoka (1952) determined by gross observation 
that phloroglucinol pretreatment could decrease mouse lung 
capillary fragil ity, utilizing a decompression hemorrhaging 
technique developed by Majovski et al. (1944). To induce 
lung hemorrhage, mice were placed in a. chamber which was 
decompressed to 40 mm Hg. The animals were removed from the 
chamber after two minutes and the lungs were excised and 
judged for extent of hemorrhage according to an arbitrary 
rating system. A capillary stabilizing effect uncovered by 
this fragility screen might find application in hypobaric 
environments or in the treatment of hypertension. 
Frieden et al. (1961) reported that phloroglucinol 
non-competitively blocks the convers ion of L-tryptophan to 
kynurenine by the liver enzyme tryptophan pyrrolase. Eighty-
one percent inhibition was achieved at a concentration of 
3.0 mM. Such an inhibition in vlvo could result in nico-
tinic acid deficiency. 
Mogey and Young (1949) investigated the in vitro effect 
of phloroglucinol on the curarized rat diaphragm. In this 
experiment, the AD66/33 of phenol, i.e., that amount of 
phenol which reduces by half the activity of an amount of 
8 
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d-tubocurarine which by itself would have effected 66.7 per-
cent paralysis, was established as a basis for the compar-
ison of the antagonism offered by other phenols. The AD66/33 
for phenol was found to be 1.52 mg. The relative activity, 
on a weight for weight basis, for phloroglucinol was found to 
be one-tenth that of phenol. Thus the authors concluded 
that phloroglucinol acted as a very weak curare antagonist. 
No inhibition of rat brain acetylcholinesterase or pseudo 
(horse serum) cholinesterase was exhibited, nor was the pH 
of the medium affected enough to alter the action of the 
. curare. Thus the mechanism of the antagonism was unexplained. 
It has been demonstrated that a variety of phenolic sub-
stances such as genistein and coumestrol possess estrogenic 
activity (Biggers and Curnow, 1954; Bickoff et al., 1958). 
The administration of such agents could result in infertil-
ity due to suppressed hypophyseal gbnadotropin resulting in 
a disturbed estrous cycle. 
Conney (1967) discussed extensively the pharmacologi cal 
implications of the alteration of the activity of the drug-
metabolizing liver microsomal enzyme system. Specifically, 
the administration of certain drugs, such as phenobarbital 
and 3-methylcholanthrene, results in enhanced metabolism of 
other agents due to induction of the enzyme system. Because 
of this important source of drug interaction, it appears 
important to test all drugs and chemical agents for the 
ability to induce or inhibit drug metabo lizing activity . 
According to Neal and DuBois ( 1965 ), metabolism of the 
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pesticide 0-ethyl 0-(4-nitrophenyl) phenylphosphonothioate 
(EPN) by rat liver microsomal enzymes provides an indication 
of the activity of that system, thus providing a method to 
investigate the effect of drugs on this metabolic pathway. 
Measurement of the anti-inflammatory activity of drugs 
is a complex problem and many methods and models have been 
proposed and utilized. Grant et al. (1970) demonstrated 
that anti-inflammatory drugs such as aspirin and indo-
methacin are often capable of inhibiting the heat denatur-
ation of bovine serum albumin solutions. Winter et al. 
(1 962 ) concluded that the polysaccharide carrageenin was 
highly suited as a phlogistin in the rat paw edema model 
of inflammation. Pearson (1956) showed that Freund's com-
plete adjuvant, a suspension of heat-killed Mvcobacterium 
butyricum in paraffin, when injected into the paw of the 
rat, could elicit a polyarthritis syndrome which could 
serve to further evaluate anti-inflammatory agents . Van 
Arman et al. (1965) described a highly sensitive mercury 
displacement plethysmograph which could be employed to 
quantitate rat paw volumes in conjunction with paw edema 
models of inflammation. The device is essentially a 
mercury-filled syringe connected to a blood pressure trans-
ducer which is in turn wired to a polygraph amplifier. The 
introduction of objects into the mercury results in a l i near 
response on the amplifier recorder. 
Many mechanisms have been proposed for the action of 
anti-inflammatory agents. Labilization of the lysoso mal 
11 
membrane and subsequent tissue dissolution due to the release 
of degradative lysosomal enzymes has been implicated as a 
mechanism underlying several types of inflammation, ranging 
from heat and chemical burns to arthritis (Houck and 
Forscher, 1968). Ignarro (1971), utilizing the release of 
the marker enzymes $-glucuronidase and acid phosphatase from 
the lysosome, has demonstrated that anti-inflammatory drugs 
are often capable of stabilizing the membrane of that 
organelle . Such stabilization may therefore partially ex-
plain the mechanism of action of many anti-inflammatory 
agents. 
Garattini et al. (1965) indicate that many chemical 
agents, such as hypertonic saline, acetic acid , and for-
maldehyde , when injected by a general route, possess anti-
inflammatory activity by virtue of ~heir irritant properties, 
which allow for a minimization of local edema formation. 
The screening of new anti-inflammatory agents must therefore 
account. for possible irritant effects. 
III EXPERIMENTAL 
A. Animals 
Sprague-Dawley derived random bred albino rats were 
obtained from Charles River Breeding Laboratories, Wilming-
ton, Massachusetts . Male rats employed weighed 200-250 g 
while female rats weighing 55-65 g were used. Male mice, 
35-42 g , were obtained from the same breeder. The animals 
were housed in quarters maintained at 21-23°c with room 
lights on alternating 12 hour li ght-dark cycles. Com-
mercial laboratory chow and wate r were allowed ad libi tum . 
Animals were used no earlier t han 3 days following receipt 
from the supplier. 
B. Materials 
Analytical grade chemi cals or equivalent were used 
throughout the study. Cofactors (NADP and glucose-6-
phosphate) and substrates (L-tryptophan , ~-nitrophenyl 
phosphate, phenolphthalein glucuronide, and acetylcholine 
chloride) were obtained from Calbiochem or Sigma Chemicals. 
Phenylbutazone and EPN were gifts of Geigy Pharmaceuticals 
and DuPont respectively. Drugs were obtained from their 
respective manufacturers. Water employed as a solvent was 
double-distilled. 
The molecular weight of the Eisenian extract has been 
12 . 
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determined to be about 10,000. The extract will be referred 
to as 40SA , preceded by letters which indicate the extraction 
batch. 
Recent evidence sugges ts that an integral part of the 
polyphenolic polymer is polysaccharide (Zelenski, 1973). 
C. Analytical Procedures 
All incubations except for determination of cholin-
esterase activity were carried out in a Dubnoff metabolic 
shaker under an atmosphere of air. All absorbance deter-
minations were made utilizing a Beckman DB-G spectrophoto-
meter . Unless otherwise indicated, all 40SA fractions 
were dissolved in water or saline. 
1. Turbidime tric Determination of Heat Denaturation of 
Bovine Serum Albumin 
The extent of heat-induced denaturation of bovine 
serum albumin (BSA) was quantitated by a method suggested 
by Grant et al. (1970). Equal amounts of 0.3% BSA and 
0 buffer or drug solution were heated at 70 C for 4 minutes, 
cooled in ice water for 3 minutes, maintained at room 
temperature for 15 minutes, and the resultant degree of 
turbidity was determined by the absorbance at 660 nm. 
The buffer employed was 0.05 M Tris acetate, pH 6.0, and 
was employed as the solvent for c40SA. Phloroglucinol 
was dissolved in buffer containing 2.5% dimethylformamide. 
2. Plethysmographic Rat Paw Volume Determination 
Rat paw volume was determined by a plethysmographic 
t e chnique described by Van Arman et al. (1965). 
) 
A 30 cc capacity syringe was filled with mercury and 
connected by means of cannula tubing to a Statham blood 
pressure transducer which in turn was wired to a Grass 
polygraph amplifier. The introduction of objects into the 
mercury resulted in a linear recorder output response from 
the amplifier. The apparatus was calibrated by the intro-
duction of objects of known volume. Rat paws were prepared 
for volume measurement by marking just above the topmost 
callus pad. Paws were im~ersed to this mark in the mercury 
during measurement . 
3. Carrageenin-Induced Rat Paw Edema 
Carrageenin was utilized as a phlogistin to induce 
rat paw edema as suggested by Winte~ et al . (1962). 
Male rats were administered (ip) either saline, 90 
mg/kg phenylbutazone, 50 mg/kg cortisone, or 75 mg/kg 
c40SA. One hour later, 0.1 ml of ~.0% carrageenin in 
saline was injected into the sub-plantar tissue of the 
hind paw, using a 26 gauge needle. The paw volume was 
determined immediately plethysmographically, and again 
three hours later, and edema formation was calculated in 
mrn3. 
4. Determination of Thermogenic Activity 
Thermo geni c activity was determined by monitoring the 
rectal temperature of rats using a Yellow Springs Instru-
ment Co. thermistor thermometer , model 8420. Saline or 
75 mg/kg or 150 mg/kg e40SA was administered (ip) to male 
rats and rectal temperature was determined (2.5 cm probe 
14 
insertion) immediately and every hour thereafter for four 
hours. Animals were housed three per cage; ambient temper-
ature was 24°c. 
15 
5. Harvesting of Lysosomes and Determination of the Activities 
of S-Glucuronidase and Acid Phosphatase 
Lysosomal fractions were prepared according to the 
method suggested by Ignarro (1971). The determination of 
the activities of the lysosomal enzymes S-glucuronidase 
and ad.d phosphatase was also performed by the method re-
ported by that author . 
The liver from a decapitated and exsanguinated male 
rat was excised and a 10 % homogenate prepared in cold 0 .2 5M 
sucrose-0.02 M Tris acetate buffer,pH 7.4. The homo-
genate (40 ml) was then centrifuge d at 600 g for 5 min at 
4°c in a Sorvall RC2-B centrifuge (·# 34 rotor). The re-
sulting supernatant was decanted and diluted with an equal 
volume of the same buffer, and cent rifuged at 3500 g for 
15 min at 4°c. The intact pellet was rinsed gently twice 
in 0.45 M sucrose-0.04% glycogen-0 .02 M Tris acetate buffer, 
pH 7.4, and resuspended in 4.0 ml of the same buffer. The 
suspensions were maintained at 4°c. 
Labilization or stabilization of lysosomes was ascer-
tained by determining the release of lysosomal marker 
enzymes. The lysosomal suspension was warmed to 25°c for 
5 min and 0.2 ml aliquots were added to 20 ml glass beakers 
containing 2.0 ml of 0.18 M sucrose-0.04 M Tris acetate 
buffer, pH 7.4, with either 0.1 ml drug solution or water, 
and the beakers were incubated at 37°c for O or 15 min in 
a Dubnoff metabolic shaker. The incubation was terminated 
by high speed centrifugation (27,000 g for 15 min at 4°c) 
after transfer of the samples to polyethylene tubes. When 
appropriate the direct effect of the drugs on the marker 
enzymes was determined. In this case the drugs were added 
to the system after the incubation period. To determine 
the total enzyme activity of the system, 2.0 ml of 0.2% 
(v/v) Triton X-100 in 0.04 M Tris acetate buffer, pH 7.4, 
replaced the 2.0 ml of buffer in the incubation. 
Acid phosphatase and 8-glucuronidase were employed as 
lysosomal marker enzymes. The formation of 2_-ni trophenol 
from E_-ni trophenyl phosphate was measured to determine ad.d 
phosphatase activity . The formation of phenolphthalein 
from phenolphthalein glucuronide was estimated to assay 
S-glucuronidase activity. One milliliter of high speed 
supernatant and 1 .0 ml of distilled water were added to 
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1.0 ml of 0.3 M citrate buffer, pH 4.8. Incubation (at 37°c 
for 20 min) was initiated by the addition of 0.04 ml of 
freshly prepared substrate (either E_-nitrophenyl phosphate, 
79 mg/ml in distilled water, or phenolphthalein glucuronide, 
63 mg/ml in distilled water). Blanks received water in 
place of substrate. Acid phosphatase determinations were 
termina ted by the addition of 0.2 ml of 4 N NaOH, and 
absorbances we r e then determi ned at 405 nm. S-glucuronidas e 
assays were terminated by the a ddit i on of o.4 ml of 2.2 M 
glycine-NaOH buffer, pH 12, and absorbances were then 
measured at 540 nm. The absorbances obtained were compared 
with those of standard solutions of phenolphthalein and 
R-nitrophenol. 
6. Freund's Adjuvant-Induced Rat Paw Edema 
Polyarthritis was induced in rats by treatment with 
complete Freund's adjuvant according to the method of 
Pollock and Brown (1971). 
Male rats were treated daily for 17 days with either 
saline (ip), 75 mg/kg f40SA adjusted to pH 7.0 with NaOH 
(ip), or 2 mg/kg triamcinolone (sc). On the second treat-
ment day, 0.1 ml Freund's complete adjuvant, containing 10 
mg heat-killed !i;icobacterium butyricum per milliliter of 
15 % mannide monooleate in paraffin oil, was injected into 
the sub-plantar tissue of the hind paw, using a 26 gauge 
needle. The paw volume was determ~ned immediately 
plethysmographically and again on day 18, and edema for-
mation calculated. 
7. Induction of Mouse Lung Hemorrhage and Lung Hemoglobin 
Determination 
Lung hemorrhage was induced by sudden decompression, a 
method developed by Majovski et al. (1944). A 30 liter 
vacuum sink was evacuated to 40 mm Hg. Mice in a 1.5 
liter test chamber at atmospheric pressure were subjected 
to the lower pressure by the opening of a stopcock. Within 
20 seconds the pressure in t he two chambers equilibrated at 
70 mm Hg. The mice died within 60-90 seconds and were 
removed from the chamber after two minutes. The lungs were 
17 
rapidly excised, weighed, homogenized in 25 volumes of 
cyanomethemoglobin reagent and centrifuged to sediment 
tissue. The supernatant was examined for hemoglobin con-
tent by determining absorbance at 540 nm. The .re maining 
homogenate was dried to constant weight at 85°c. Results 
18 
were reported as mg hemoglobin per mg dry lung. The re-
sulting values were compared to those of control animals 
maintained at atmospheric pressure. Animals were admin-
istered (ip) saline, 300 mg/kg e40SA, 300 mg/kg phloroglucinol, 
or 100 mg/ kg pl~enylbut azone 1.5 hours prior to sacrifice. 
8. In vivo Antagonism of Curare, Strychnine, or Tetrodotoxin 
in Mice 
Lethal doses of curare, strychnine, or tetrodoto xin 
were administered to mice to investigate antagonism to 
t hes e agents. The Eisenian extract at a dose of 300 mg/kg 
or saline was administered intraperitoneally to mice 30 
minutes prior to the administration (ip or sc) of either 
curare (0.28-0.60 mg/kg) , strychnine (2.0 mg/kg), or 
tetrodotoxin (12 µg/kg). These doses are close to the 
respective LD50
1 s. The number of animals injected and 
the number of survivo rs were recorded. 
9, Determinat ion of Acetylcholinesterase Activity 
The activity of rat brain acetylcholinesterase was 
estimated by the manometric method suggested by DuBois and 
Mangun (1 947) employing the Warburg apparatus. 
Male rats were administered (ip) either saline or 300 
mg/kg ec40SA one hour prior to sacrifice for brain excision . 
Ten percent brain homogenates were prepared in calcium-
free Ringer-bicarbonate buffer . One-half milliliter of 
homogenate and 2.2 ml buffer were transferred to the main 
compartment of the Warburg flask. In vitro experiments in-
cluded the addition of ec40SA at a concentration of 5 mg/ml 
to the main compartment. The flasks were flushed for 5 
minutes with 95:5 N2 :co2 while they equilibrated to the 
temperature of the water bath (38°c). The reaction was 
initiated by tipping into the main compartment the contents 
of the side-arm ·(0.3 ml of 0.1 M acetylcholine chloride). 
After another 5 minute equilibration, the manometer read-
ings of the amount of co 2 produced by the enzymatic 
hydrolysis of the acetylcholine were recorded at 5 minute 
intervals for 30 minutes. The co 2 production was corrected 
for both tissue and acetylcholine blanks and for thermo-
barometer changes. 
10. Cat Sciatic Nerve-Gastrocnemius Muscle Preparation 
The in vivo cat sciatic nerve-gastrocnemius muscle 
preparation was utilized to quant itate curare antagonism. 
A 3.2 kg cat was anesthetized with 1.5 g/kg urethane 
(ip). The left jugular vein was cannulated and used for 
infusion of drugs. The right carotid artery was cannulated 
and connected to a Statham blood pressure transducer which 
was in turn wired to a Grass polygraph amplifier to monitor 
blood pressure. Forty units/kg of heparin were infused to 
prevent clotting . An automatic respirator was connected 
to a tracheal cannula. The left gastrocnemius muscle was 
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connected to a Grass force transducer which was in turn 
wired to a Grass polygraph amplifier to record muscle 
activity. The left sciatic nerve received a 1.0 V 
stimulus lasting 0.1 msec at a rate of 12/minute. This 
stimulus effected an initial contractile force of 980 
dynes. d-Tubocurarine chloride was infused until a 70 % 
reduction in contractile force was obtained. The follow-
ing drugs were infused, in order, over periods of 3, 6, 
or 9 minutes respectively: 0.18 mg physostigmine, 30 mg 
phloroglucinol, or 180 mg e40SA. Additional curare was 
infused between drugs as needed to reinstate the reference 
curarization level. 
11. Determination of 0-Ethyl 0-(4-nitrophenyl) phenylphos-
phonothioate Detoxification. 
The detoxification of 0-ethyl 0-(4-nitrophenyl) 
phenylphosphonothioate (EPN) was estimated by measuring 
the formation of the resultant £-nitrophenol according to 
the method of Neal and DuBois (1965). 
To an incubation mixture containing 1.3 µmoles NADP, 
3.3 µmoles glucose-6-phosphate, 0.2 ml EPN-buffer and suf-
ficient water to make a total volume of O. 8 ml was added 
0.1 ml 20% rat liver homogenate in 1.15% KCl containing 
O. 25 % nicotinamide. 'l'he EPN-buffer was prepared by dis-
solving 7.0 mg EPN in 1.0 ml 1:4 ethanol: propylene glycol 
and adding 0.5 ml of this solution to 5.0 ml of 0.1 M 
phosphate buffer, pH 7.8. 
Incubation was carried out at 37°c for 60 min . The 
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reaction was terminated by adding 2.5 ml cold acetone to 
the reaction flask. The flask contents were transferred 
to centrifuge tubes containing 0.2 ml glycine-NaOH buffer 
(0.5 M, pH 9.5). The tubes were centrifuged and the 
absorbance of the supernatant was determined at 410 nm 
versus a blank to which tissue had been added at the 
termination of the incubation. The amount of £-nitrophenol 
formed was determined by comparison with the absorbance of 
known quantities of the chemical. 
12 . Determination of L-Tryptophan Pyrrolase Activity 
L-tryptophan pyrrolase activity of rat liver homoge-
nates was estimated through assay of the end product 
kynurenine, according to the method of Knox and Mehler 
(1 95 0). 
Incubations were carried out at 37°c for 60 minutes 
in media containing 7.5 mmoles L-tryptophan, 2.0 ml of 
0.1 M phosphate buffer, pH 7.0, and 0.8 ml 25% liver 
homogenate in 0.15 M KCl in a total volume of 4.0 ml. 
Por in vitro investigation, 1.94 mg of phloroglucinol or 
f40SA was added. To examine the in vivo effects of drugs 
on the enzyme, animals were injected (ip) 1.5 hours prior 
to sacrifice with saline, 300 mg/kg phloroglucinol, or 
300 mg/kg e40SA; or with 35 mg/kg hydrocortisone four 
hours prior to sacrifice for liver excision. 
The reaction was terminated by the addition of 2.0 
ml of 15% metaphosphoric acid. The flask contents were 
filtered and a 3.0 ml aliquot of the filtrate was 
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neutralized with 1.0 ml of 1 N NaOH. The absorbance was 
then determined at 365 nm versus a blank to which the . 
homogenate had been added after the metaphosphoric acid. 
The amount of kynurenine formed was calculated from the 
absorbance of solutions of kynurenine of known concen-
tration. 
13. Determination of Estrogenic Activity 
To determine estrogenic activity, immature female 
rats were injected daily for three days with either 
saline (ip), 308 .mg/kg f40SA (ip), or 25 µg/animal 
estradiol-17-B(sc). The estradiol was prepared by 
diluting 1.0 ml of a 25 mg/100 ml 95% ethanol stock 
solution with 4.0 ml saline . On the fourth day, the 
uterus was excised, weighed, and the uterine-to-body 
weight ratio calculated. 
D. Statistical Methods 
The 2-tailed Student's "t" test for independent means 
was used to examine experimental means for statistical 
significance. The level of significance (P) was determined 
by comparison of the computed"t" value with values from 
standard tables. All calculated "t" values were tested 
at both the 0.05 and 0.01 probability levels for 




The extract was initially evaluated by means of the 
albumin denaturation test , which is used to screen new 
drugs for anti-inflammatory activity. The results of this 
screening proced~re are shown in Tables 1 and 2 . Table 1 
sho;;s that the heat denaturation of a 0 . 15% bovine serum 
albumin solution was inhibited 96% by the addition of the 
extract at a final concentration of 0.32 mg/ml, and that 
there was a dose dependent relationship at lower concen-
trations. '1.'able 2 shows th::tt the mo.del compound, 
phloroglucinol, enhanced by at least 24% the denaturation 
process. 
Since the extract exhibited activity in the in vitro 
anti-inflammatory test system, determination of its effect 
in an intact animal model of inflammation would be valuable. 
Table 3 summarizes the results of an anti-inflammatory 
study employing as a model carrageenin-induced rat paw 
edema. The extract, administered at a dose of 75 mg/kg (ip) 
one hour prior to carrageenin injection, inhibited edema 
formation by 88%. The administration of the potent anti-
inflammatory agent phenylbutazone (90 mg/kg) inhibited 
edema production by 100% and also allowed for a partial 
absorption of the injected carrageenin. Administration of 
23 
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·Table 1. Effect of C40SA on heat denaturation 
of bovine serum albumin. 
c40SA 
CONCENTRATION 
ABSO RBANCEa mg/ml r CONTROL 
o.o .620 100 
0.005 .550 89 
0.01 .560 90 
0.02 • 340 55 
0.04 .345 56 
0.08 .049 8 
0.16 .036 6 
0.32 .022 4 
o.64 .090 15 
aDeterrnined at 660 nm. 
~able 2. Effect of phlordglucinol on heat 
denaturation of bovine serum albumin. 
-PHLOROGLUCINOL 
ABSORBANCE a CONCENTRATION % CONTROL 
mg/ml 
0.0 0.76 100 
0.50 1.00 132 
0.25 l. 00 132 
0.125 1. 00 132 
0. 062 1.00 132 
0. 031 1.00 132 
0.015 1.10 145 
0.0075 0.95 125 
0. 00 37 0.96 126 
0.0018 0.94 124 
0.0009 1.10 145 
aDetermined at 660 nm. 
. 25 . 
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Table 3. Effect of drugs on carrageenin-induced 
rat paw edema. 
· TREATMENTa MEAN EDEMA ± SE 2 mm 3 (4)b -% CONTROL 
Saline 1363 ± 206 100 
cl40SA 163 ± 69C 12 
( 75 mg/kg, ip) 
Phenylbutazone -100 ± 71c 
-7 (90 mg/kg, ip) 
Cortisone 738 ± 97d 54 
(50 mg/kg, ip) 
a . Drugs were administered 1 hour prior to carrageenin 
injection. 
bNumber of animals. 
the steroid cortisone (50 mg/kg ) inhibited edema formation 
by 46%. The effects of the above drugs were significant 
at the P<.05 level. 
Several experiments were undertaken to determine the 
mechanism of action of the extract as an anti-inflammatory 
agent in the carrageenin paw edema system. The first of 
these, a study of the effect of the extract on rat body 
temperature, is summarized in Figure 1. The extract, at 
a dose of either 75 or 150 mg/kg, had a negligible effect 
on body temperature over a period of four hours. 
Since some compounds have been shown to possess anti-
inflammatory activity due to irritant properties, an ex-
pe riment was conducted to determine whether the extract 
was an irritant by virtue of its acidity. The carrageenin 
paw edema model was again employed, and the extract, at a 
dose of 100 mg/kg, was either buffered at or neutralized to 
pH 7.4. Table 4 shows the results of this study. The 
neutralized extract did not offer statistically significant 
protection (76% of control) while the buffered material 
inhibited edema formation by 42% (P .< .05). 
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Stabilization of the lysosomal membrane has also been 
invoked as a me chanism of action of various anti-inflammatory 
agents. The degree of stabilization or labilization can be 
inferred from the extent of release of the lysosomal marker 
enzymes acid phosphatase and S-glucuronidase. The extract 
was so examined for it s effect on the lysosomal membrane. 
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Figure l. Effect bf e40SA on rat body temperatu:re. 
Animals were administered either saline 
or e40SA ( 75 or 150 mg/ kg 1 ip ) and 
rectal temperature · was monitored 0ver a 
period of 4 hours. Each point r .e~>resents 
the mean temperature of.' 3 a.."1.imalo ~ 
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-Table 4. Effect of neutralized or buffered ec40SA on 
carrageenin-induced rat paw edema. 
TREATMENTa MEAN EDEMA ± SE, mm3 
' 
(6)b % CONTROL 
Saline 1174 ± 99 100 
c Neutralized 898 ± 181 76 {100 mg/kg, ip) 
d Buffered 678 ± 176e 58 ( 100 mg/kg, ip) 
aDrugs were administered 1 hour prior to carrageenin 
injection. 
bNurnber of animals. 
cNeutralized to pH 7.4 with NaOH. 
dBuffered at pH 7.4 with 0.2 M KH 2Po 4-Na2HP0 4 . 
ep < • 05 
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The enzyme activities reported are corrected for direct drug 
inhibition, if any. Table 5 shows that acid phosphatase 
activity is insensitive as an indicator of lysosomal mem-
brane condition, since the powerful stabilizing agent 
phenylbutazone inhibited enzyme release by only 7%. How-
ever, phenylbutazone (0.309 mg/ml) and the extract at a 
concentration of either 3.087 or 0.309 mg/ml offered signifi-
cant (P < .01) inhibition of release of 8-glucuronidase 
(30, 36, and 36 per cent of control respectively). 
Phloroglucinol and 0.031 mg/ml f40SA were ineffective. 
Table 6 shows that the extract retains its lysosomal 
membrane stabilizing ability even when further chemically 
purified. The refined material offered statistically 
significant (P < .01) inhibition of release of 
B-glucuronidase (43% of control ). 
The extract was further tested for anti-inflammatory 
activity by means of the Freund 's adjuvant-induced rat paw 
ede ma model of arthritis . Table 7 summarizes the results 
of this study. The potent steroid triamcinolone inhibited 
ede ma formation by 77% (P < .05), iri contrast to the ex-
tract, which provided negligible protection against this 
type of inflammation. 
Capillary fragility 
The effect of the extract on capillary fragility as 
determined by lung hemoglobin content following sudden 
decompression was examined. Table 8 is a summary of this 
study. None of the drugs tested, which included e40SA, 
Table 5. Effect of drugs on lysosornal membrane stability 
in vitro. 
ENZYME ACTIVITYa ± SE (4)b (% CONTROL) 
· DRUG 
ACID PHOSPHATASEc S-GLUCURONIDASEd 
None 4·. 46 ± 0.16 (100) o.66 ± 0.02 (100) 
Phlorogl ud.nol 4.48 ± 0. 41 (100) o.68 ± 0.02 (10 3) (0.309 mg/ml) 
Phenylbutazone 4.13 ± 0.08 (93) 0.20 ± 0.01 (30)f (0.309 mg/ml) 
f40SA 3.66 ± 0.22 (82)e 0.24 ± 0.03 (36)f (3.087 mg/ml) 
f40SA 3.64 ± 0.16 ( 82)e 0.24 ± 0.01 ( 36) f (0.309 mg/ml) 
f 40SA 3.83 ± 0.22 ( 86) o.64 ± 0.02 (97) (0.031 mg/ml) 
aE.xpressed as µmoles product/ml lysosomal fraction/20 min. 
bNumber of animals . 
cDetermined at 405 nm. 
d 
at 540 Determined nm. 




Table 6. Effect of f40SA and refined 40SA on lysosomal 
membrane stability in vitro. 
DRUG B-GLUCURONIDASE ACTIVITYa ± SE (4)b (%CONTROL) 
None 0.53 ± 0.04 (100) 
f40SA 0.20 ± 0.03 (38)c (0.309 mg/ml) 
Refined 40SA 0.23 ± 0.02 (43)c (0.309 mg/ml) 
aExpressed as µmoles phenolphthalein/ ml lysosornal 
fraction/ 20 min., determined at 540 nm. 
bNumber of animals. 
c p < .01. 
Table 7. Antagonism of Freund's adjuvant-induced 
rat paw edema 
TREATMENT a MEAN EDEMA ± SE 2 mm3 (6)b %- CONTROL 
Saline 3920 ± 983 100 
Triamcinolone 911 ± 153c 23 ( 2 mg/kg , s c ) 
f40SAd 3079 ± 286 79 (75 mg/kg, ip) 
aDrugs were administered daily for 17 days; adjuvant 
injected on second treatment day. 
bNumber of animals. 
Cp < • 05 
dAdjusted to pH 1.0 with NaOH. 
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Table 8. Effect of drugs on the mouse lung hemmorrhage 
induced by sudden decompression. 
TREATMENTa ' b MEAN mg HEMOGLOBIN /mg DRY LUNG ± SE(4)c 
TABLE CHAMBER 
Saline 0.136 ± 0.005 0.154 ± 0.007 
eliQSA 0.145 ± 0.009 0.164 ± 0.006 (300 mg/kg, ip) 
Phloroglucinol 0.129 ± 0.005 0.152 ± 0.008 (300 mg/kg, ip) 
Phenylbutazone 0.165 ± 0.025 0.170 ± 0.006 (100 mg/kg, ip) 
8 Drugs were administered 1.5 hours prior to decompression. 
bDeterminedat 540 nm. 
cNumber of animals. 
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phloroglucinol, and phenylbutazone, reduced capillary 
fragility in this test system. 
Curare, strychnine, and tetrodotoxin poisoning 
The extract was tested for its ability to protect 
against poisoning in mice induced by curare, strychnine, 
or tetrodotoxin. Table 9 shows that if both curare and 
the extract were administered intraperitoneally, there 
existed protection against curare lethality. As shown in 
Table 10, if the curare was administered subcutaneously 
and the extract intraperitoneally, no protection was 
exhibited by the extract. 
Further experimentation was performed to investigate 
the mechanism of action of the apparent curare antagonism 
of the extract. Table 11 shows that the material had a 
negligible in vivo effect on rat brain cholinesterase 
activity, in contrast to an in vitro inhibition of 53% 
(P < .01). The extract was also tested for its in vivo 
effect on the curarized cat gastrocnemius muscle. Jugular 
infusion of 180 mg of e40SA over a period of nine minutes 
exhibited no effect on the curarized muscle, in contrast 
to the anticholinesterase agent physostigmine, wh~ch com-
pletely restored contractile force after infusion of 0.18 
mg over a period of three minutes. 
To determine whether the extract might protect against 
poisoning due to other agents, its effects on strychnine 
and tetrodotoxin lethality were examined. In both cases, 
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Table 9. Protection against curare poisoning in 
mice by e40SA. 
CURARE DOSE NUMBER OF SURVIVORS 
(mg/k.g, ip) SALINE e40SA (300 mg/kg 2 
0. 30 5/5b 5/5 
0.37 3/5 5/5 
o.45 2/5 4/5 
0.52 1/5 5/5 
0.60 0/5 5/5 
aAdministered 30 minutes prior to curare injection. 
b Number of survivors/number injected. 
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Table 10. Protection against curare poisoning in 
mice by ec40SA. 
CURARE DOSE NUMBER OF SURVIVORS 
(mg/kg, sc) 
-SALINE ec40SA (300 mg/kg, 
0.28 lt/5b 5/5 
0.36 3/5 lt/5 
0. 1~4 2/5 2/5 
0.52 1/5 0/5 
0.60 0/5 0/5 
aAdministered 30 minutes prior to curare injection. 
bNumber of survivors/number injected. 
37 , 
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~able 11. Effect of ec40SA in vivo and in vitro on rat 
brain cholinesterase activity-. -
TREATMENT MEAN ENZYME ACTIVITYa ± SE (3)b . % CONTROL 
Saline 2.96 ± 0.20 100 
ec40SA 
(30 0 mg/kg,ip )c 3.17 ± 0.16 107 
ec40SA 1.38 ± 0.16d 47 (5 mg/ml) 
aExpressed as µmoles ACh/50 mg brain/10 min. 
bNumber of animals. 
cAdministered one hour prior to sacrifice. 
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the poison and the extract were administered by the intra-
peritoneal route. Tables 12 and 13 show that the extract 
does not protect against the lethality of either strychnine 
or tetrodotoxin, respectively . 
Liver microsomal enzymes 
The possible effect of the extract on the activity of 
the drug-metabolizing hepatic microsomal enzyme system was 
determined by measuring the effect of the extract on the 
metabolism of the pesticide EPN. Table 14 surrunarizes the 
results of the experiment. The classical inducing agent 
phenobarbital significantly increased microsomal enzyme 
activity by more than 4-fold (P < .01). The extract was 
ineffective in inducing this system after three days of 
treatment or in inhibiting the activity when given 60 
minutes before sacrificing the animals. 
~tophan pyrrolase 
Table 15 summarizes the effects of various drugs on 
rat liver tryptophan pyrrolase activity. In vi VO 
administration of hydrocortisone and f40SA resulted in 
increased enzyme activity (322 % control, P < .01) and 
inhibition (67% control, P < .01), respectively. In vivo 
administration of phloroglucinol had no effect on the 
enzyme act1.vity, while the in vitro effect of phloroglucinol 
was that of inhibition (~8% control, P < .01). The 
presence of the Eisenian extract resulted in an in vitro 
inhibition of 82% (P < .01). 
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Table 12. Effect of ec40SA on strychnine poisoning in 
mice. 
STRYCHNINE ROUTE NU MBER OF SURVIVORS 
(2 mg/kg) SALINE ec40sA· (300 mg/kg, ip)a 
ip 0/4b 0/4 
SC 0/4 0/4 
aAdministered 30 minutes prior to strychnine injection. 
bNumber of survivors/number injected. 
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Table 13. Effect of f40SA on tetrodotoxin poisoning 
in mice. 
TREATMENTa NUMBER OF SURVIVORS 
Saline l/4b 
f40SA 
(300 mg/kg, ip) 1/6 
aAnimals were administered 12 µg/kg (ip) tetrodotoxin 
30 min after protecting agent. 
bHumber of survivors/number injected. 
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Table 14. Effect of drugs on EPNa detoxification. 
TREATMENT MEAN ENZYME ACTIVITYb ± SE . % CONTROL 
Saline 1.8 ± 0.1 (6)c 100 
Phenobarbital 7.8 ± 0.5 (3)d 433 (3 days, 50 mg/kg, ip) 
e40SA 1.4 ± 0.3 (3) 77 (3 days, 300 mg/kg, ip) 
e40SA 2.0 ± 0.1 (3) 111 ( 1 hr. , 300 mg/kg, ip) 
aO-ethyl 0-4-nitrophenyl phenylphosphonothioate 
v 
bActivity expressed as µg PNP/50 mg liver/hr. 
cNumber of animals. 
Table 15. Effect of drugs in vivo and in vitro on rat 
liver tryptophan{)yrrolase activity. 
TREATMENT MEAN ENZYME ACTIVITYa ± SE (4)b % 
Saline c 20.6 ± 0.5 
Hydrocortisoned 66.4 ± l.9e ( 35 mg/kg, ip) 
Phloroglucinolc 19.8 ± 0.3 ( 300 mg/kg, ip) 
f40SA 
c 13.7 ± 0.2e (300 mg/kg, ip) 
Phloroglucinol 9.9 ± 0. 3e (4 86 µg/ml) 
f 40SA 3.7 ± 0.2e ( 4 86 µg/ml 
aExpressed as µmoles kynurenine/g liver/hr. 
bNumber of animals. 
cAdministered 1.5 hours prior to sacrifice. 











The extract was tested for possible estrogenic 
activity by examining its ability to alter the uterine to 
body weight ratio in immature female rats. Table 16 shows 
t he results of the study. Estradiol-17-8 increased the 
ratio more than 2-fold (P < .01), while the extract had 
no effect on the ratio. 
Table 16. Effect of drugs on rat uterine weight. 
TREATMENTa Uterine Wt. x 103 ± S.E. (5)b % CONTROL Body Wt . 
Saline (ip) 0.69 ± 0.06 100 
Estradiol 1. 64 ± o.o6c 238 (0 .5 µg/rat, sc) 
ec40SA 0.61 ± 0.04 88 (300 mg/kg, ip) 
aDrugs were administered daily for 3 days. 
bNumber of animals . 
V DISCUSSION 
Inflammation 
The extract was initially evaluated for pharmacological 
activity utilizing the albumin heat denaturation screening 
test for anti-inflammatory drugs . A large number of anti-
:i.n.flammat ory drugs have been shown to inhibit the heat de-
naturation o f albumin solutions ( Grant ~al., 1970). Heat 
denaturation is able to produce albumin aggregates which 
are i mmunologically distinct from the parent protein 
(Maurer , 1959). Such aggregates are known to occur spon-
taneously ( Foster~ al., 1965); these spontaneous aggre-
gates behave as anti gens in the etiology of at least one 
i mmuno- inflammatory disease, serum sickness nephritis 
(Lirenman et al., 1967). 
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The extract inhibited albumin denaturation by 96 %, as 
shown in Table 1, in contrast to the denaturation enhance-
ment afforded by the model comp ound, phloroglucinol (Table 
2). While the mechanism of such a stabilization is presently 
unknown , it is possible that hydrogen bonding occurs between 
the extract and the protein, thus increasing the stability 
of the molecular structure. 
The in vitro anti-inflammatory screen was followed by 
in vivo anti-,inflammatory determinations utilizing the 
carrageenin-induced rat paw e dema model of inflammation, 
which is least influenced by non-specific factors (Garattini 
et al., 1965). The mechanism by which carrageenin, a high 
molecular weight polysaccharide, induces paw edema is as 
controversial as the mechanisms of action of the agents which 
inhibit this edema formation. The following have been in-
voked as mediators of carrageenin-induced edema: kinins and 
5-hydroxytryptamine (5-HT) ( Crunkhorn and Meacock, 1971), 
histamine (DiRos a et al., 1971), and activation of the comple-
ment system (DiRosa, 1972). It is possible that the apparent 
complement s ys tem activation reflects a mild antigen-antibody 
response to carrageenin, since high molecular weight poly-
saccharides as well as proteins are capable of eliciting such 
a response (Porter, 1967). Thus, 5-HT and histamine release 
may be secondary to comp lement activation. 
Administration of the extract one hour prior to car-
rageenin injection inhibited the formation of edema by 88 %. 
Accordingly, various experiments were undertaken to determine 
the mechanism of action of this protection. Since stimula-
tion of the adrenal cortex, either directly or indirectly 
via the hypothalamus or pitui tary, can be related to anti-
inflammatory activity, the action of the extract was compared 
with that of a large dose of cortisone (50 mg/kg, ip), which 
inhibited edema production by 46 %. Since cortisone afforded 
only one-hal f the inhibition offered by the extract, it is 
unlikely that the extract could stimulate the production or 
release of sufficient corticosteroid to reduce inflammation 
by the extent exhibited. 
The thermogenic activity of new anti-inflammatory com-
pounds must be determined since the peripheral vasodilation 
which would accompany a rise in body temperature might 
either promote edema, due to increased capillary permeabil-
ity, or reduce edema, by more rapid removal of phlogistin. 
The extract was tested for its effect on body temperature, 
and it can be concluded from Figure 1 that the extract had 
a negligible effect on body temperature over a period of 
four hours. Thus the anti-inflammatory activity of the 
extract is not based on thermogenic effects. 
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Garattini et al., (1965) have shown that various com-
pounds, when injected by the intraperitoneal route, can 
inhibit edema formation in various models of inflammation 
due to their properties as irritants. A partial basis for 
this phenomenon is decreased availability of circulating 
fluid due to the draining of water into the peritoneal 
cavity. Accordingly, an experiment was undertaken to 
determine if the extract was an irritant by virtue of its 
acidity. Employing the carrageenin model, extract was 
tested which was maintained at pH 7.4 either by phosphate 
buffering or sodium hydroxide neutralization. The results 
of the experiment are shown in Table 4, and it is evident 
that although the anti-inflammatory potency of the extract 
has been decreased by neutralization, the buffered material 
retains statistically significant anti-inflammatory activity 
which is one-half that of non-adjusted, acidic extract 
solution. Thus the mechanism of action of the extract can 
be partially, but not fully, explained on the basis of its 
irritancy. 
Labi lization of t he lysosomal membrane is known to 
occur at sites of inj ury and has also been implicated as a 
major factor in the development of inflammation, since 
lysosomal enzymes possess the capacity to degrade completely 
the components of the connective tissue, such as collagen , 
protein-mucopolysaccharide complexes, glycoprotein, and 
elast in (Houck and Forscher, 1968; Ignarro, 1971). Many 
anti.-inflammatory agents have been shown to stabilize the 
lysosomal membrane through their inhibition of the release 
of the marker enzymes B-glucuronidase and acid phosphatase 
from lysosomal preparations. The extract was examined 
in this manner. It can be concluded from the data in Table 5 
that the extract is as effective as phenylbutazone as a 
lysosomal membrane stabilizing agent. 
Since the crude extract might contain an impurity which 
would account for the lysosomal membrane stabilization, a 
refined sample of the extract was also tested for its ability 
to inhibit the release of 8-glucuronidase from lysosomal 
preparations. The results, s11mmarized in Table 6, show that 
the refined material is as effective as the crude in its 
ability to stabilize the lysosomal membrane . 
The extract was further tested for anti-inflammatory 
activity by means of the adjuvant arthritis model, which 
is a delayed hypersensitivity reaction. Table 7 shows the 
results of the study, and it can be concluded that the 
extract exerted no anti-inflammatory effect against this 
type of inflammation . The mechanism by which effective 
agents, such as triamcinolone, combat this model of 
arthritis is obscure, but may be in part due to lysosomal 
stabilization (Pollock and Brown, 1971). 
An hypothesis may be formulated to account for the con-
trasting effects of the extract on the two in vivo models 
of inflammation. 11 Prima1•y" membrane stabilization ( stabili-
zation of membranes of whole cells, e.g., basophils, 
platelets, or mas t cells) and "secondary" membrane stabili-
zation {stabilization of the membranes of cell organelles, 
e.g. lysosomes) apparently are involved in the etiology of 
both carrageenin and Freund's edeffia. The extract has been 
shown to stabilize at least one type of membrane, that of 
the lysosome. However, Freund's edema may be more difficult 
to suppress than carrageenin edema because of overwhelming 
participation of the immunity mechanism in the case of the 
former. 
The extract, by virtue of its polysaccharide content, 
might also act as a counter-irritant. 
Capillary fragility 
The extract was examined for its ability to decrease 
capillary fragility. It should be noted that the method of 
Majovski (1944) was employed except in the comparison of 
different treatments, for which a quantitative spectre-
. photometric assay for hemoglobin was used in place of the 
arbitra ry qualitative assay originally described. 
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The method employed is non-specific in that the under-
lying mechanism of a stabilizing agent cannot be di.fferenti-
ated from the known possibilities, which include effects on 
the 1) endothelial cell membrane, 2) endothelial cell junc-
tion, and 3) sources of possible chemical intermediates 
(such as basophils, and platelets, and plasma kinins). 
None of the drugs tested enhanced capillary stability 
I 
(Table 8) in contrast to the effect of phloroglucinol re-
ported by Okanishi and Shimaoka (1952). Close examination 
of the results shows that the method is not sufficiently 
sensitive to quantitate the possible stabilizing effects of 
drugs, inasmuch as the chamber control animals exhibited 
only a 13% increase in lung hemoglobin compared to the non-
chamber animals. This increase is not statis tically 
significant. 
Curare, strychnine , and tetrodotoxin poisoning 
The extract was tested for its effecti veness as an 
antagonist against curare, strychnine, and tet rodotoxin, 
because of the report of Mogey and Young (1949) that 
phloroglucinol acted as a mild curare ant agonist in vitro. 
These three agents act on the nervous sys tem dissimilarly: 
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1) curare, the classical neuromuscular blccker, competitively 
blocks postjunctional acetylcholine recep or sites, 2) 
strychnine, a CNS stimulant, acts by bloc~i ng post-synaptic 
inhibition, and 3) tetrodotoxin selective ly blocks axonal 
conduction. 
Since the extract was ineffective in pre venting curare 
poisoning when administered via a different route than that 
of the curare, in contrast to the protection exhibited when 
the routes of administration were identical (Tables 9-10), 
a true pharmacological antagonism would seem an unlikely 
mechanism of action of the extract. This was supported by 
demonstrating that 1) the extract was an ineffective in 
vivo cholinesterase inhibitor (Table 11) and 2) the extract 
exerted no antagonism to the action of curare on the in 
vivo cat gastrocnemius muscle-sciatic nerve preparation. 
An alternative mechanism of action might be based on 
the occurrence of a chemical interaction of the negatively 
charged extract molecule with the positively charged 
quaternary nitrogen of the curare molecule. Further ex-
perimentation in this context failed to support such a 
mechanism: while no protection was offered against the 
lethality of strychnine, which contains an uncharged 
tertiary nitrogen (Table 12), neither was there protection 
against poisoning by tetrodotoxin which contains a 
positively charged guanidinium group (Table 13). An 
untested hypothesis for the curare protection might be an 
inhibition of absorption of the curare from the peritoneal 
cavity. 
Liver mi cro somal enzymes 
In order to more fully characterize the action of a 
new drug, its interaction with other drugs must be 
examined. One potential site of drug interaction is the 
liver microsomal electron transport system, an enzyme 
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system which is responsible for the biotransformation of a 
wide variety of drugs and other chemical agents. Most 
important relative to drug interactions are the stimulation 
(induction) and inhibition of the system. 
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The extract was tested for possible microsomal induction 
or inhibition (Table 14) by measuring the effect on the 
metabolism of the insectide EPN. The extract was observed 
to have no effect on microsomal enzymes after administration 
daily for three days or one hour following a single dose. 
Tryptophan P.l.~.;olase 
Tryptophan pyrrolase, located in the soluble fraction 
of the liver cell, catalyzes the cleavage of the indole ring 
from the nutritionally essential amino acid tryptophan. The 
resultant product, formyl kynurenine, is readily hydrolyzed 
to kynurenine. Tryptophan pyrrolase is important not only 
for tryptophan degradation but also for the conversion of 
tryptophan to niacin. The enzyme is inducible; known induc-
ing agents include adrenal corticosteroids and tryptophan 
itself. 
Investigation of the effect of the extract on the 
activity of tryptophan pyrrolase would provide a more com-
plete characterization of the effects of the extract on 
liver metabolism, in conjunction with the effects exerted on 
the microsomal enzyme system, especially since Frieden et al. 
(1961) reported that phloroglucinol inhibited tryptophan 
pyrrolase in vitro. Such an investigation wa s carried out 
and the results, shown in Table 15, indicate that the 
extract, both in vivo and in vitro, caused enzyme inhibition. 
Such inhibition could result in nicotinic acid deficiency or 
i.n increased synthesis of serotonin, which might result in 
stimulation of cerebral activity. 
Rat uterus 
A variety of naturally occurring phenolic materials 
have been shown to exhibit estrogenic activity (Biggers and 
Curnow, 1954); the widespread metabolic consequences of 
such activity seemed sufficient justification for determin-
ing ~1e ther the extract acted in a similar manner. 
The uterus, target organ for estrogen, is most frequently 
employed to bioassay for estrogenic activity . The response 
of this organ to estrogenic stimulation is biphasic in 
nature: initially, hyperemia and imbibition of water occur, 
followed later by hypertrophy and hyperplasia; thus an 
increase in the uterine to body weight ratio can be demon-
strated. 
The extract was found to cause neither estrogenic 
stimulation nor retrogression of this organ (Table 16). 
VI SUMMARY AND CONCLUSIONS 
1. An eitract from Eisenia bicyclis containing principally 
a polyphenolic polymer inhibited the heat denaturation 
of a 0.15% bovine serum albumin by 96% when added to 
the i ncubation medium at a concentration of 0.32 mg/ml. 
This was suggestive of possible anti-inflammatory 
activity. 
2. As determined by paw volume changes , administration of 
the extract at a dose of 75 mg/kg one hour prior to 
carrageenin injection inhibited edema production by 88%. 
3. The ability of the extract to suppress carrageenin 
edema was apparently not due to pituitary-adrenal 
stimulation, since a large dose of cortisone (50 mg/kg) 
provided only one-half the protection afforded by the 
extract. Nor was the anti-inflammatory effect due to 
changes in body temperature, which remained unchanged 
over a period of four hours after administration of a 
dose of either 75 or 150 mg/kg. 
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4. The anti-inflammatory effect of the extract was parti ally 
due to its irritant properties, since buffering a dose 
of 100 mg/kg provided only one-half the protection 
afforded by a non-buffered dose. The extract may also 
act against inflammation by stabilizing the lysosomal 
membrane, since in vitro 309 ~g of the extract per 
milliliter of incubation medium inhibited by 64% the 
release of the marker enzyme e-glucuronidase from rat 
liver lysosomes . 
5. The extract administered at a dose of 75 mg/kg daily 
for 17 days offered no protection against rat paw 
edema induced by Freund's complete adjuvant . 
6. No decrease in capillary fragility of the mouse lung, 
as determined by hemoglobin content following sudden 
decompressi on, was observed 1.5 hours after pretreat-
ment with the extract at a dose of 300 mg/kg .. 
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7. The material administered to mice at a dose of 300 mg/kg 
30 minutes prior to administration of lethal doses of 
curare exhibited protection against curare poisoning 
only if the routes of administration were identical. 
8. The mechanism of action of the apparent curare antagon-
ism of the extract appeared to be chemical rather than 
pharmacological, since the material had no effect on 
either the curarized cat gastrocnemius muscle in vivo 
or the activity of rat brain cholinesterase in vivo. 
An exact chemical mechanism cannot be formulated be-
cause the material was ineffective in preventing 
poisoning by either another positively charged toxin, 
tetrodotoxin, or an uncharged poison, strychnine. 
9. The extract was observed to have no effect on liver 
microsomal enzyme activity after administr~tion of 300 
mg/kg daily for three days or one hour following a 
single dose of 300 mg/kg. 
10. The administration of the extract at a dose of 300 
mg/kg 1.5 hours prior to sacrifice resulted in 33% 
inhibition of the activity of tryptophan pyrrolase. 
The presence of the extract at a concentration of 
486 µg/ml resulted in an in vitro inhibition of 82%. 
11. The extract, administered at a dose of 300 mg/kg 
daily for three days, did not alter the uterine to 
body weight ratio in immature female rats. 
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